IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockDiscovery themes featuring this stock| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
17.29 | 975 Cr | 23.56 | 2.54 | 0.00 | 10.79 | 13.40 | 6.91 | ||
84.57 | 950 Cr | 43.48 | 4.57 | 0.00 | 10.51 | 13.42 | 7.43 | ||
148.90 | 808 Cr | -63.09 | 1.85 | 0.00 | -2.94 | -5.52 | -2.25 | ||
383.80 | 807 Cr | 35.85 | 9.70 | 0.00 | 27.03 | 33.41 | 27.34 | ||
218.00 | 448 Cr | 37.15 | 2.23 | 0.00 | 7.03 | 8.76 | 49.60 | ||
374.15 | 397 Cr | 17.65 | 3.41 | 0.27 | 19.30 | 18.09 | 11.27 | ||
190.55 | 348 Cr | 78.80 | 2.82 | 0.00 | 3.64 | 5.22 | 2.95 | ||
| Median: 7 Co. | — | 190.55 | 807 Cr | 35.85 | 2.82 | 0.00 | 10.51 | 13.40 | 7.43 |
Bearish
4
Neutral
6
Bullish
4
Bearish
12
Neutral
6
Bullish
28
Bearish
8
Neutral
0
Bullish
24
Bearish
8
Neutral
0
Bullish
24
Bearish
8
Neutral
0
Bullish
24
Bearish
8
Neutral
0
Bullish
24
Quick Heal Technologies develops and sells cybersecurity software for consumers, small and medium businesses, enterprises, defence, and government across Windows, Mac, Android, Linux, desktops, laptops, servers, mobiles, and tablets. Its principal brands are Quick Heal for consumers and Seqrite for enterprise and government customers.
The company is undergoing a difficult but strategically important transition from consumer antivirus toward enterprise cybersecurity. Management attributed the long-term consumer decline partly to operating-system providers, particularly Microsoft, distributing security protection by default, while positioning Seqrite’s endpoint, EDR, XDR, and data-privacy offerings for future growth.
Q2 FY2027 showed a sharp sequential recovery: consolidated revenue increased 44% quarter-on-quarter to INR 65 crore, EBITDA moved from a INR 17.6 crore loss to a INR 2.3 crore profit, and PAT reached INR 5.8 crore. However, revenue remained 22% below the prior-year quarter, highlighting that recovery is not yet equivalent to sustained growth.
Working-capital discipline is becoming a significant management priority. Receivables declined to INR 98 crore from INR 107 crore in Q1 and INR 176 crore a year earlier, reflecting tighter partner credit controls, although management acknowledged that these actions may moderate near-term consumer volumes.
Quick Heal Technologies has built a substantial innovation pipeline, including EPP, XDR, ZTNA, data privacy, Go Deep.AI, AntiFraud.AI, Seqrite Intelligent Assistant, Seqrite Threat Intel, and SMAP. The central investment question is whether these capabilities can convert into repeatable enterprise adoption, stronger monetization, and consistent operating leverage.
IT - Software
Software Products
808 Cr
High Risk
-63.1
18.8
—
1.9
336.30
125.00
Sales CAGR
Profit CAGR
ROE
ROCE
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Other
Quick Heal Technologies allotted 1,210 equity shares under its ESOP Scheme 2021 on November 5, 2026.
Earnings Call/Transcript
Quick Heal Technologies released the transcript of its Q2 and H1 FY27 earnings call held on October 28, 2026.
Quick Heal Technologies Ltd (QUICKHEAL) is currently trading at 150.05 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Quick Heal Technologies develops and sells cybersecurity software for consumers, small and medium businesses, enterprises, defence, and government across Windows, Mac, Android, Linux, desktops, laptops, servers, mobiles, and tablets. Its principal brands are Quick Heal for consumers and Seqrite for enterprise and government customers. The company is undergoing a difficult but strategically important transition from consumer antivirus toward enterprise cybersecurity. Management attributed the long-term consumer decline partly to operating-system providers, particularly Microsoft, distributing security protection by default, while positioning Seqrite’s endpoint, EDR, XDR, and data-privacy offerings for future growth. Q2 FY2027 showed a sharp sequential recovery: consolidated revenue increased 44% quarter-on-quarter to INR 65 crore, EBITDA moved from a INR 17.6 crore loss to a INR 2.3 crore profit, and PAT reached INR 5.8 crore. However, revenue remained 22% below the prior-year quarter, highlighting that recovery is not yet equivalent to sustained growth. Working-capital discipline is becoming a significant management priority. Receivables declined to INR 98 crore from INR 107 crore in Q1 and INR 176 crore a year earlier, reflecting tighter partner credit controls, although management acknowledged that these actions may moderate near-term consumer volumes. Quick Heal Technologies has built a substantial innovation pipeline, including EPP, XDR, ZTNA, data privacy, Go Deep.AI, AntiFraud.AI, Seqrite Intelligent Assistant, Seqrite Threat Intel, and SMAP. The central investment question is whether these capabilities can convert into repeatable enterprise adoption, stronger monetization, and consistent operating leverage.
Over the past 52 weeks, Quick Heal Technologies Ltd has traded between a low of ₹125.00 and a high of ₹336.30. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Quick Heal Technologies Ltd has a market capitalization of approximately 808.17. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Quick Heal Technologies Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -63.09 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 808.17 Cr, Quick Heal Technologies Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Quick Heal Technologies Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Quick Heal Technologies Ltd is -63.09. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Quick Heal expects enterprise cybersecurity to contribute more than 80% of total revenue within the coming three years. Management described this as an expectation during its October 28, 2026 earnings call, not as formal financial guidance. It did not provide a total-revenue or margin target.
Quick Heal reported total revenue of ₹44.99 crore for the quarter ended June 2026, compared with ₹57.23 crore in June 2025.
The company said it closed the trading window ahead of the declaration of un-audited financial results for the quarter ended June 30, 2026, in line with SEBI insider trading regulations.
The board meeting is scheduled for July 30, 2026.
